Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Orchestra BioMed Holdings (OBIO) Non-Current Debt (2022 - 2025)

Historic Non-Current Debt for Orchestra BioMed Holdings (OBIO) over the last 4 years, with Q3 2025 value amounting to $14.2 million.

  • Orchestra BioMed Holdings' Non-Current Debt changed N/A to $14.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $14.2 million, marking a year-over-year change of. This contributed to the annual value of $14.3 million for FY2024, which is N/A changed from last year.
  • Orchestra BioMed Holdings' Non-Current Debt amounted to $14.2 million in Q3 2025.
  • In the past 5 years, Orchestra BioMed Holdings' Non-Current Debt ranged from a high of $14.4 million in Q2 2025 and a low of $9.5 million during Q4 2022
  • Its 4-year average for Non-Current Debt is $12.3 million, with a median of $14.2 million in 2025.